Literature DB >> 10430219

Role of human papillomaviruses in cutaneous and oral manifestations of immunosuppression.

I M Leigh1, J A Buchanan, C A Harwood, R Cerio, A Storey.   

Abstract

Long-term immunosuppressive drug regimes, used to prevent organ transplant rejection, are associated with an increased risk of epithelial malignancies particularly anogenital and cutaneous cancers. Premalignant and malignant lesions of the oral mucosa have also been reported in renal transplant recipients (RTRs), particularly of sun-exposed lip lesions. Many of these anogenital lesions are associated with the detection of high-risk mucosal human papillomaviruses (HPV). Novel degenerate and nested polymerase chain reaction (PCR) techniques have found high levels of epidermodysplasia verruciformis (EV) HPVs (high-risk cutaneous oncogenic HPVs) in cutaneous warts, dysplastic keratoses, and squamous cell carcinomas. Unusual appendageal and spindle cell carcinomas are being observed in RTRs. Increasing survival times of HIV-positive patients may be associated with dysplasia of orogenital mucosal epithelium, and careful epidemiologic studies of cutaneous lesions are needed. The role of HPVs in the development of these lesions has yet to be established.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10430219

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  6 in total

1.  Human Papillomavirus Vaccination Rates in Young Cancer Survivors.

Authors:  James L Klosky; Melissa M Hudson; Yanjun Chen; James A Connelly; Karen Wasilewski-Masker; Can-Lan Sun; Liton Francisco; Laura Gustafson; Kathryn M Russell; Gina Sabbatini; Jessica S Flynn; Jocelyn M York; Anna R Giuliano; Leslie L Robison; F Lennie Wong; Smita Bhatia; Wendy Landier
Journal:  J Clin Oncol       Date:  2017-08-24       Impact factor: 44.544

Review 2.  Guidelines for assessing immunocompetency in clinical trials for autoimmune diseases.

Authors:  R John Looney; Betty Diamond; V Michael Holers; Marc C Levesque; Larry Moreland; Moon H Nahm; E William St Clair
Journal:  Clin Immunol       Date:  2007-02-27       Impact factor: 3.969

3.  [Guidelines for vaccination of immunocompromised individuals].

Authors:  Ursula Wiedermann; Harald H Sitte; Heinz Burgmann; Alexander Eser; Petra Falb; Heidemarie Holzmann; Maria Kitchen; Marcus Köller; Herwig Kollaritsch; Michael Kundi; Hans Lassmann; Ingomar Mutz; Winfried F Pickl; Elisabeth Riedl; Maria Sibilia; Florian Thalhammer; Barbara Tucek; Werner Zenz; Karl Zwiauer
Journal:  Wien Klin Wochenschr       Date:  2016-07-25       Impact factor: 1.704

4.  Sexual behaviors and human papillomavirus vaccine non-initiation among young adult cancer survivors.

Authors:  Brooke Cherven; James L Klosky; Yanjun Chen; Jocelyn M York; Karen Heaton; Gwendolyn Childs; Jessica S Flynn; James A Connelly; Karen Wasilewski-Masker; Leslie L Robison; Melissa M Hudson; F Lennie Wong; Smita Bhatia; Wendy Landier
Journal:  J Cancer Surviv       Date:  2021-02-06       Impact factor: 4.442

5.  Identification of a novel human papillomavirus by metagenomic analysis of vaginal swab samples from pregnant women.

Authors:  Zhijian Liu; Shixing Yang; Yan Wang; Quan Shen; Yan Yang; Xutao Deng; Wen Zhang; Eric Delwart
Journal:  Virol J       Date:  2016-07-04       Impact factor: 4.099

6.  Genetic characterization of the first chiropteran papillomavirus, isolated from a basosquamous carcinoma in an Egyptian fruit bat: the Rousettus aegyptiacus papillomavirus type 1.

Authors:  Annabel Rector; Sara Mostmans; Koenraad Van Doorslaer; Christy A McKnight; Roger K Maes; Annabel G Wise; Matti Kiupel; Marc Van Ranst
Journal:  Vet Microbiol       Date:  2006-07-18       Impact factor: 3.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.